UNIVERSITY OF EXETER has floated a tender for Optical Electromyography Probe. The project location is United Kingdom and the tender is closing on 02 Apr 2024. The tender notice number is MAR469409, while the TOT Ref Number is 98234296. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : United Kingdom

Summary : Optical Electromyography Probe

Deadline : 02 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98234296

Document Ref. No. : MAR469409

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : UNIVERSITY OF EXETER
University of Exeter
RC000653
Northcote House
Exeter
EX4 4QH
UK
Contact person : Megan Brine
Telephone : +44 1392723333
E-mail : m.brine@exeter.ac.uk
NUTS : UKK
Internet address(es)
Main address : http : //www.exeter.ac.uk
Address of the buyer profile : https : //uk.eu-supply.com/ctm/Company/CompanyInformation/Index/53042

United Kingdom
Email :m.brine@exeter.ac.uk
URL :http://www.exeter.ac.uk

Tender Details

Production of Optical Electromyography probes in accordance with the specifications set out in the University's Invitation to Tender documents.



Title: Optical Electromyography Probe

OCID: ocds-h6vhtk-044542

Published by: University of Exeter

Authority ID: AA20363

Publication Date: 05/03/2024

Deadline Date: 02/04/2024

Deadline Time: 12:00

Notice Type: Contract Notice

Has Documents: No

Has SPD: No

Abstract: A team of academics and clinicians from the Universities of Exeter and Bristol, Sheffield Teaching Hospitals NHS Foundation Trust, and lead by the University of Sheffield have funding from the Medical Research Council DPFS to develop a device to perform an “optical EMG” to advance the diagnosis of nerve and muscle disorders.Nerve and muscle diseases (‘neuromuscular diseases-) comprise a heterogeneous group of disorders that can be difficult to diagnose, often requiring multiple tests and several years to arrive at a diagnosis. While many of these conditions are, at present, incurable, there are therapeutics undergoing clinical trials. As a result, biomarkers for the diagnosis and monitoring of neuromuscular diseases are more important than ever.In this project we propose an ‘optical EMG-, a combination of electromyography, a standard clinical test that records the electrical activity arising from muscle, and optical spectroscopy, a light-based technique that provides additional information on a sample using a laser....

Documents

 Tender Notice